İnfektif Endokardit ile Başvuran Hastalarda Hastane İçi Mortalitenin Öngördürücüleri; Tek Merkezli Çalışma

Kaynakça (3)

1. Kılıç O. ve Yılmaz S. İnfektif Endokardit ile Başvuran Hastalarda Hastane İçi Mortalitenin Öngördürücüleri; Tek Merkezli Çalışma. MN Kardiyoloji 2018;25(4):182-6
2. Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endo- carditis. Am J Cardiol. 2007;99(10):1429-33. PubMed PMID: 17493474. Turak O, Canpolat U, Ozcan F. et al. D-dimer level predicts in-hospital mortality in patients with infective endocardi- tis: a prospective single-centre study. Thromb Res 2014;134(3):587-92.
3. Turak O, Ozcan F, Isleyen A, Basar FN, Gul M, Yilmaz S, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in- hospital outcomes in infective endocarditis. Can J Cardiol. 2013;29(12):1672-8. PubMed PMID: 23916736. Kocazeybek B, Kucukoglu S, Oner YA. Procalcitonin and C- reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 2003;49(1-2):76- 84. PubMed PMID:12714816. Tok D, Canpolat U, Tok D, Turak O, Isleyen A, Oksuz F, et al. Association of mean platelet volume level with in-hospital major adverse events in infective endocarditis. Wien Klin Wochenschr 2015;127(5-6):197-202. PubMed PMID: 25777146. Tugcu A, Yildirimturk O, Baytaroglu C, Kurtoglu H, Kose O, Sener M, et al. Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey. Turk Kardiyol Dern Ars 2009;37(1):9-18. PubMed PMID: 19225248. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001;142(1):75-80. PubMed PMID: 11431660.